(Alliance News) - Ergomed PLC on Tuesday said it has appointed the founder and former chief executive of Biotrace International PLC to its board as a non-executive director.
Ian Johnson will join Ergomed, which provides specialised services such as contract research and trial management to pharmaceutical companies, with immediate effect.
In addition to having founded Biotrace, which was sold in 2006, Johnson has also been non-executive chair of Celsis Group Ltd and chair of Cyprotex PLC. Johnson was also chair of Quantum Pharma PLC.
Johnson was most recently executive chair of Bioquell PLC, until it was acquired by Ecolab Inc in January 2019.
Ergomed Executive Chair Miroslav Reljanovic said: "We are pleased to welcome Ian to the board. This appointment continues a series of measures we began more than a year ago to drive long term growth through a focus on our services business and to strengthen the board and management team. Ian has spent his career in the life sciences industry and has a strong track record in building shareholder value. We look forward to his contributions as we continue towards our goal of building a leading independent global mid-tier [contract research organisation]."
Shares in Ergomed were up 1.6% at 328.00 pence on Tuesday afternoon in London.
